SLC16A12
Monocarboxylate transporter 12
Also known as: MCT12, MOT12_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZSM3
- Gene
- SLC16A12
- Ensembl
- ENSG00000152779
- Chromosome
- 10
- Canonical length
- 516 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a transmembrane transporter that likely plays a role in monocarboxylic acid transport. A mutation in this gene has been associated with juvenile cataracts with microcornea and renal glucosuria. [provided by RefSeq, Mar 2010]
Canonical amino-acid sequenceUniProt
516 residues, UniProt reviewed canonical sequence.
>Q6ZSM3|SLC16A12
1 MPSGSHWTAN SSKIITWLLE QPGKEEKRKT MAKVNRARST SPPDGGWGWM IVAGCFLVTI
61 CTRAVTRCIS IFFVEFQTYF TQDYAQTAWI HSIVDCVTML CAPLGSVVSN HLSCQVGIML
121 GGLLASTGLI LSSFATSLKH LYLTLGVLTG LGFALCYSPA IAMVGKYFSR RKALAYGIAM
181 SGSGIGTFIL APVVQLLIEQ FSWRGALLIL GGFVLNLCVC GALMRPITLK EDHTTPEQNH
241 VCRTQKEDIK RVSPYSSLTK EWAQTCLCCC LQQEYSFLLM SDFVVLAVSV LFMAYGCSPL
301 FVYLVPYALS VGVSHQQAAF LMSILGVIDI IGNITFGWLT DRRCLKNYQY VCYLFAVGMD
361 GLCYLCLPML QSLPLLVPFS CTFGYFDGAY VTLIPVVTTE IVGTTSLSSA LGVVYFLHAV
421 PYLVSPPIAG RLVDTTGSYT AAFLLCGFSM IFSSVLLGFA RLIKRMRKTQ LQFIAKESDP
481 KLQLWTNGSV AYSVARELDQ KHGEPVATAV PGYSLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC16A12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- kidney: 79 nTPM
- choroid plexus: 56 nTPM
- epididymis: 49 nTPM
- pancreas: 24 nTPM
- seminal vesicle: 13 nTPM
- placenta: 11 nTPM
Single-cell type
- proximal tubule cells: 1,235 nCPM
- choroid plexus epithelial cells: 589 nCPM
- loop of henle epithelial cells: 504 nCPM
- retinal pigment epithelial cells: 418 nCPM
- epididymal principal cells: 150 nCPM
- leydig cells: 140 nCPM
Immune cell
- basophil: 0.3 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 194 nTPM
- hippocampal formation: 6.6 nTPM
- cerebral cortex: 6.3 nTPM
- midbrain: 4.1 nTPM
- spinal cord: 3.3 nTPM
- basal ganglia: 3.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC16A12.
Disease | AllUniProt
Conditions SLC16A12 is implicated in, by any mechanism.
- Cataract 47 (CTRCT47) MIM:612018
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 146 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Juvenile cataract-microcornea-renal glucosuria syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.49
- gnomAD missense Z
- 0.95
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 0% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC16A12 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC16A12 as an antibody target. Whether an autoantibody or antibody against SLC16A12 could matter depends on whether native SLC16A12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC16A12 is annotated at the cell surface, where native SLC16A12 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC16A12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...